Aveanna Healthcare (AVAH) to Release Quarterly Earnings on Thursday

Aveanna Healthcare (NASDAQ:AVAH) is projected to issue its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of $0.13 per share for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, March 19, 2026 at 10:00 AM ET.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $7.42 on Thursday. The company has a 50-day simple moving average of $8.19 and a 200-day simple moving average of $8.55. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23. The company has a market cap of $1.55 billion, a PE ratio of 20.61 and a beta of 2.07. Aveanna Healthcare has a 12 month low of $3.67 and a 12 month high of $10.32.

Wall Street Analysts Forecast Growth

AVAH has been the subject of several analyst reports. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd. William Blair started coverage on Aveanna Healthcare in a research note on Monday, December 8th. They issued an “outperform” rating for the company. Barclays increased their target price on Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a research report on Friday, January 16th. UBS Group lifted their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a report on Thursday, January 15th. Finally, Raymond James Financial reiterated an “outperform” rating and set a $13.00 price objective on shares of Aveanna Healthcare in a report on Friday, December 5th. Five investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Aveanna Healthcare presently has an average rating of “Hold” and an average price target of $11.06.

Insider Activity

In other news, CFO Matthew Buckhalter sold 13,512 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $97,421.52. Following the completion of the sale, the chief financial officer owned 529,243 shares of the company’s stock, valued at $3,815,842.03. This represents a 2.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Deborah Stewart sold 11,181 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $80,615.01. Following the completion of the transaction, the chief accounting officer directly owned 301,807 shares of the company’s stock, valued at approximately $2,176,028.47. The trade was a 3.57% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 998,595 shares of company stock worth $7,567,770. Insiders own 7.80% of the company’s stock.

Hedge Funds Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new position in Aveanna Healthcare during the 2nd quarter valued at approximately $43,000. Oxford Asset Management LLP acquired a new position in shares of Aveanna Healthcare during the second quarter valued at $64,000. Bayesian Capital Management LP bought a new position in shares of Aveanna Healthcare during the second quarter worth about $85,000. Jain Global LLC acquired a new stake in shares of Aveanna Healthcare in the 4th quarter worth about $102,000. Finally, Invesco Ltd. lifted its position in Aveanna Healthcare by 31.1% in the 2nd quarter. Invesco Ltd. now owns 20,006 shares of the company’s stock valued at $105,000 after purchasing an additional 4,742 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.